Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit)

v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
Series 2 Preferred Stock [Member]
Preferred Stock Member
Series 1 Preferred Shares Member
Preferred Stock Member
Common Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2022       $ 79,101,061 $ (195,369) $ (80,253,464) $ (1,347,772)
Balance at the beginning (in shares) at Dec. 31, 2022   70,000,000 8,579,284        
Changes in Shareholders' Deficit              
Share-based compensation       132,510     132,510
Foreign currency translation         (4,354)   (4,354)
Net Income (Loss)           (4,959,431) (4,959,431)
Balance at the end at Mar. 31, 2023       79,233,571 (199,723) (85,212,895) (6,179,047)
Balance at the end (in shares) at Mar. 31, 2023   70,000,000 8,579,284        
Balance at the beginning at Dec. 31, 2023       97,590,426 (371,184) (93,465,946) $ 3,753,296
Balance at the beginning (in shares) at Dec. 31, 2023 1,166,667   18,885,254       18,885,254
Changes in Shareholders' Deficit              
Share-based compensation       63,584     $ 63,584
Issuance of Common Shares from ATM Offering, net of issuance costs (shares)     75,862        
Issuance of Common Shares from ATM Offering, net of issuance costs (value)       190,274     190,274
Re-measurement of liability-classified CAD stock options as of March 31, 2024       (294,967)     (294,967)
Net Income (Loss)           (3,635,088) (3,635,088)
Balance at the end at Mar. 31, 2024       $ 97,549,317 $ (371,184) $ (97,101,034) $ 77,099
Balance at the end (in shares) at Mar. 31, 2024 1,166,667   18,961,116       18,961,116